ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
만성 폐쇄성 폐질환 가상현실 치료 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 11억 5,000만 달러에서 2025년에는 13억 8,000만 달러에 달하고, CAGR 19.7%로 확대될 전망입니다. 실적기간 내 성장은 만성 폐쇄성 폐질환(COPD)의 유병률 증가, 비약물 치료적 개입에 대한 수요 증가, 디지털 건강 솔루션의 채택 증가, 비용 효율적인 재활 옵션의 필요성 증가, 원격 치료의 이점에 대한 인식 증가와 관련이 있습니다.
만성 폐쇄성 폐질환 가상현실 치료 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 19.3%로 28억 달러로 성장할 전망입니다. 예측기간 중에 예측되는 성장은 가정 재활의 채용 증가, 헬스케어의 디지털화와 원격의료 확대, 신흥 시장에서의 헬스케어 지출 증가, 디지털치료제에 대한 지원적인 환급정책, 병원 재입원 감소 중점화 등이 원동력이 되고 있습니다. 예측 기간 동안의 주요 동향에는 맞춤 치료를 위한 가상현실(VR)과 인공지능의 통합, 원격 폐 재활을 위한 클라우드 기반 플랫폼의 이용, 몰입형 호흡 운동을 위한 촉각 피드백의 통합, 호흡기 건강 시뮬레이션을 위한 디지털 트윈 채용, 실시간 모니터링을 위한 웨어러블 센서 등이 있습니다.
가상현실 치료에 대한 인식과 수용 증가는 만성 폐쇄성 폐질환 가상현실 치료 시장의 성장을 가속화할 것으로 예측됩니다. 가상현실 치료는 몰입형 기술을 사용하여 치료 및 재활을 위한 대화형 환경을 제공합니다. 통증과 불안을 줄이고 환자에게 비침습적이고 약물을 사용하지 않는 옵션을 제공함으로써 치료 경험과 치료 효과를 높일 수 있기 때문입니다. 인지도 또한 환자와 의료 제공업체를 교육하고 디지털 재활 솔루션의 사용을 장려함으로써 채용을 뒷받침합니다. 또한 사용자가 몰입형 테라피에 익숙해지면 참여도가 높아져 어드레싱과 건강 결과가 향상됩니다. 예를 들어 미국 제대군인부는 2024년 7월 170개가 넘는 VA 의료 센터와 외래 진료소에 약 3,500대의 가상현실 헤드셋이 배치되어 치료 목적으로 사용할 수 있는 수가 3배로 늘었다고 보고했습니다. 이러한 인식과 수용 증가는 COPD 가상현실 치료 시장의 성장을 뒷받침하고 있습니다.
맞춤 의료에 대한 관심 증가는 만성 폐색성 폐질환 가상현실 치료 시장의 확대를 뒷받침할 것으로 예측됩니다. 맞춤 의료는 개인의 유전적 프로파일, 라이프스타일, 환경에 따라 치료 및 예방 전략을 맞춤화하는 것입니다. 유전체학의 발전으로 유전자 변이를 정확하게 확인하고 맞춤형 치료를 제공할 수 있게 되었습니다. 맞춤 의료는 몰입형 재활 프로그램을 각 환자의 특정 요구에 맞추어 적응시킴으로써 COPD 가상현실 치료를 강화하고 치료 효과와 집중력을 높입니다. 환자 고유의 증상과 능력, 기호에 대응하여 치료 결과가 향상되고 환자의 관여와 어드히어런스가 강화됩니다. 예를 들어, 2024년 2월 맞춤의료연합(Personalized Medicine Coalition)은 미국 식품의약국이 2023년에 26개 개별화 신약을 승인했다고 보고했습니다. 이와 같이 맞춤 의료가 중시되면서 COPD 가상현실 치료 시장을 전진시키고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 만성 폐쇄성 폐질환 가상현실 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 성장률 분석
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 만성 폐쇄성 폐질환 가상현실 치료 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 컴포넌트별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
하드웨어
소프트웨어
서비스
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
몰입형 가상현실 치료
비몰입형 가상현실 치료
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
폐 재활
환자 교육
통증 관리
불안과 스트레스의 경감
기타 용도
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
진료소
가정 치료 환경
기타 최종 사용자
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 세분화 : 하드웨어 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
가상현실 헤드셋
모션 센서
촉각 피드백 기기
웨어러블 모니터
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 세분화 : 소프트웨어 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
폐 재활 애플리케이션
환자 모니터링 플랫폼
데이터 분석 도구
치료 게이미피케이션 소프트웨어
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 세분화 : 서비스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
원격 폐 치료
기술지원
트레이닝 및 교육
시스템 통합
제7장 지역별/국가별 분석
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 만성 폐쇄성 폐질환 가상현실 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
만성 폐색성 폐질환 가상현실 치료 시장 : 경쟁 구도
만성 폐색성 폐질환 가상현실 치료 시장 : 기업 프로파일
Rush University Medical Center : 개요, 제품 및 서비스, 전략 및 재무 분석
Penumbra Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Burke Rehabilitation Hospital : 개요, 제품 및 서비스, 전략 및 재무 분석
MindMaze SA : 개요, 제품 및 서비스, 전략 및 재무 분석
XRHealth Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Jolly Good Inc.
AppliedVR Inc.
Carda Health Inc.
Lincare Inc.
Virtually Better Inc.
Wellinks Inc.
Breathe Better Rehab
Kivo Health Inc.
VRelax BV
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
만성 폐쇄성 폐질환 가상현실 치료 시장(2029년) : 새로운 기회를 제공하는 국가
만성 폐색성 폐질환 가상현실 치료 시장(2029년) : 새로운 기회를 제공하는 부문
만성 폐색성 폐질환 가상현실 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Chronic obstructive pulmonary disease (COPD) virtual reality therapy is a non-pharmacological treatment approach that uses immersive virtual reality environments to support respiratory rehabilitation, enhance lung function, and increase patient engagement. It combines interactive exercises, breathing techniques, and real-time feedback to help patients manage symptoms and improve overall quality of life. This therapy is increasingly integrated into digital health solutions for home-based and clinical pulmonary care.
The primary components of COPD virtual reality therapy include hardware, software, and services. Hardware refers to virtual reality headsets, sensors, wearables, and related devices used to deliver immersive, interactive therapies for pulmonary rehabilitation, breathing exercises, and symptom management in COPD patients. Therapy types include immersive and non-immersive virtual reality approaches. Applications cover pulmonary rehabilitation, patient education, pain management, anxiety and stress reduction, and other areas. Key end users include hospitals, clinics, home care settings, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The chronic obstructive pulmonary disease virtual reality therapy market research report is one of a series of new reports from The Business Research Company that provides chronic obstructive pulmonary disease virtual reality therapy market statistics, including the chronic obstructive pulmonary disease virtual reality therapy industry global market size, regional shares, competitors with the chronic obstructive pulmonary disease virtual reality therapy market share, detailed chronic obstructive pulmonary disease virtual reality therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease virtual reality therapy industry. This chronic obstructive pulmonary disease virtual reality therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The chronic obstructive pulmonary disease virtual reality therapy market size has grown rapidly in recent years. It will grow from $1.15 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 19.7%. The growth during the historic period is linked to the increasing prevalence of chronic obstructive pulmonary disease (COPD), growing demand for non-pharmacological interventions, rising adoption of digital health solutions, need for cost-effective rehabilitation options, and greater awareness of the benefits of remote therapy.
The chronic obstructive pulmonary disease virtual reality therapy market size is expected to see rapid growth in the next few years. It will grow to $2.80 billion in 2029 at a compound annual growth rate (CAGR) of 19.3%. The growth projected for the forecast period is driven by increasing adoption of home-based rehabilitation, expanding healthcare digitization and telemedicine, rising healthcare expenditure in emerging markets, supportive reimbursement policies for digital therapeutics, and greater focus on reducing hospital readmissions. Primary trends during the forecast period include integration of virtual reality (VR) with artificial intelligence for personalized therapy, use of cloud-based platforms for remote pulmonary rehabilitation, incorporation of haptic feedback for immersive breathing exercises, adoption of digital twins for respiratory health simulation, and integration with wearable sensors for real-time monitoring.
Growing awareness and acceptance of virtual reality therapy are expected to drive growth in the chronic obstructive pulmonary disease virtual reality therapy market. Virtual reality therapy uses immersive technology to create interactive environments for treatment and rehabilitation. The increasing recognition of this therapy stems from its ability to reduce pain and anxiety, providing patients with a non-invasive, drug-free option that enhances treatment experiences and results. Awareness boosts adoption by educating patients and providers, encouraging the use of digital rehabilitation solutions. It also improves engagement by familiarizing users with immersive therapy, resulting in better adherence and health outcomes. For example, in July 2024, the U.S. Department of Veterans Affairs reported that approximately 3,500 virtual reality headsets were deployed across over 170 VA medical centers and outpatient clinics, tripling the number available for therapeutic purposes. This rise in awareness and acceptance is fueling the growth of the COPD virtual reality therapy market.
The growing focus on personalized medicine is also expected to support expansion of the chronic obstructive pulmonary disease virtual reality therapy market. Personalized medicine customizes treatment and prevention strategies based on an individual's genetic profile, lifestyle, and environment. Advances in genomics have made it possible to identify genetic variations precisely and provide tailored treatments. Personalized medicine enhances COPD virtual reality therapy by adapting immersive rehabilitation programs to meet each patient's specific needs, increasing treatment effectiveness and focus. It improves outcomes by addressing unique symptoms, abilities, and preferences, which strengthens patient engagement and adherence. For instance, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a notable rise from 12 approvals in 2022. This growing emphasis on personalized medicine is propelling the COPD virtual reality therapy market forward.
In March 2025, Wellinks Inc., a digital healthcare company based in the United States, formed a partnership with CareAbout Health to broaden virtual-first COPD management programs within value-based care networks. This collaboration seeks to improve patient outcomes, lower hospitalization rates, and increase access to comprehensive home pulmonary care. CareAbout Health is a healthcare management company in the U.S. that supports virtual COPD care initiatives.
Major players in the chronic obstructive pulmonary disease virtual reality therapy market are Inova Health System, Rush University Medical Center, Penumbra Inc., Burke Rehabilitation Hospital, MindMaze SA, XRHealth Inc., Jolly Good Inc., AppliedVR Inc., Carda Health Inc., Lincare Inc., Virtually Better Inc., Wellinks Inc., Breathe Better Rehab, Kivo Health Inc., and VRelax B.V.
North America was the largest region in the chronic obstructive pulmonary disease virtual reality therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic obstructive pulmonary disease virtual reality therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the chronic obstructive pulmonary disease virtual reality therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic obstructive pulmonary disease virtual reality therapy market consists of revenues earned by entities by providing services such as virtual pulmonary rehabilitation programs, guided breathing and relaxation sessions, remote respiratory therapy, patient education and training modules, tele-rehabilitation support, gamified exercise sessions, and social interaction platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic obstructive pulmonary disease virtual reality therapy market also includes sales of virtual reality (VR) headsets, motion controllers, haptic feedback devices, specialized respiratory training software, cloud-based therapy platforms, and virtual reality (VR)-enabled monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chronic obstructive pulmonary disease virtual reality therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic obstructive pulmonary disease virtual reality therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic obstructive pulmonary disease virtual reality therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Hardware; Software; Services
4. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
